Mechanism of action of chloroquine/ hydroxychloroquine for COVID-19 infection

The article by Dr. Alberto Boretti and colleagues is published in Coronaviruses, 2020
1-Dec-2020 1:55 PM EST, by Bentham Science Publishers

Newswise — The recent serious outbreak of Covid19 has affected (November 13, 2020) 53,796,098 people worldwide, resulting in 37,555,669 recovered, 1,310,250 deaths (Figure 1), and a large number of open cases. It has required urgent medical treatments for numerous patients. No clinically active vaccines or antiviral agents are available for Covid19. According to several studies, Chloroquine (CQ) and Hydroxychloroquine (HCQ) have shown promises as Covid19 antiviral especially when administered with Azithromycin (AZM). However, there is significant controversy. Many countries are limiting the use of CQ/HCQ, while others are accepting this therapeutical option (Figure 2). The work [1] is addressing the open question if Chloroquine (CQ) and Hydroxychloroquine (HCQ) are helpful in Covid19 infection by analyzing the latest published literature on the subject while applying the scientific method.

Both papers in favor, or against, this therapeutical option are reviewed [1]. Bias by a conflict of interest is also taken into account. The rationale behind this use is clear. CQ/HCQ is effective against Covid19 in-vitro and in-vivo laboratory studies. Therapy in Covid19 infected patients with CQ/HCQ is supported by evidence of trials and field experiences from multiple sources. The relevant works are reviewed. The presence or absence of conflict of interest is weighed against the conclusions. CQ/HCQ has been used with success in mild cases or medium severity cases. No randomized controlled trial has however been conducted to support the safety and efficacy of CQ/HCQ and AZM for Covid19. Prophylaxis with CQ/HCQ is more controversial, but generally not having side effects, and supported by pre-clinical studies. The mechanism of action against Covid19 is unclear. More research is needed to understand the mechanisms of actions CQ/HCQ have against Covid19 infection, and this requires investigations with nanoscale imaging of viral infection of host cells. Most of the published works indicate CQ/HCQ is likely effective against Covid19 infection, almost 100% in prophylaxis and mild to medium severity cases, and 60% in late infection cases. The percentage of positive works is larger if works conducted under a probable conflict of interest are excluded from the list. The result is consistent with the updated analysis provided in [2], [3], that suggests high efficacy of CQ/HCQ in early treatments and lower efficacy and controversial results only for late treatment. Statistically, 100% of early treatment studies are positive, late treatment studies are mixed with 70% positive effects, 78% of pre-exposure prophylaxis studies are positive, and 100% of post-exposure prophylaxis studies also report positive effects [2], [3].

###

SEE ORIGINAL STUDY



Filters close

Showing results

110 of 6133
Released: 5-Aug-2021 2:30 PM EDT
Research Shows Many with Mild COVID-19 Infections Still Experience Long-Term Symptoms
University of Arizona Health Sciences Center

The majority of individuals who experience mild or moderate COVID-19 infection also experience long COVID, or persistent symptoms more than 30 days after they test positive, according to research data from the longitudinal CoVHORT study at the University of Arizona Health Sciences.

Released: 5-Aug-2021 2:10 PM EDT
Should COVID-19 Vaccination Be Mandatory for Health and Care Staff?
BMJ

Italy, France, and Greece have made covid-19 vaccination mandatory for healthcare workers, and England is making it compulsory for care home workers and consulting on whether to extend this to healthcare workers and other social care staff.

Newswise: Organ Transplant Recipients Significantly Protected by COVID-19 Vaccination
Released: 5-Aug-2021 1:55 PM EDT
Organ Transplant Recipients Significantly Protected by COVID-19 Vaccination
University of California San Diego Health

UC San Diego researchers report that solid organ transplant recipients who were vaccinated experienced an almost 80 percent reduction in the incidence of symptomatic COVID-19 compared to unvaccinated counterparts during the same time.

Newswise: Statement: Employers Need to Require COVID-19 Vaccination for Healthcare Workforce
Released: 5-Aug-2021 1:30 PM EDT
Statement: Employers Need to Require COVID-19 Vaccination for Healthcare Workforce
American Association of Critical-Care Nurses (AACN)

The American Association of Critical-Care Nurses calls for all healthcare and long-term-care employers to require every member of the healthcare team to be vaccinated against COVID-19, except when medically contraindicated.

Newswise: 17d548cf-cfe0-4673
Released: 5-Aug-2021 1:10 PM EDT
Heads Reveal How ‘Overwhelming’ Government Guidance Held Schools Back as COVID Hit
University of Cambridge

Headteachers and school leaders have described how an ‘avalanche’ of confused and shifting Government guidance severely impeded schools during the critical first months of COVID lockdown in a new study.

Released: 5-Aug-2021 10:55 AM EDT
AMSSM Partners with White House and 11 Organizations to Encourage Vaccine Conversations During Sports Physicals
American Medical Society for Sports Medicine (AMSSM)

AMSSM and 11 other leading sports and medical organizations signed on to a consensus statement to encourage healthcare providers to include conversations about COVID-19 vaccinations as part of the pre-participation physical.

Newswise: August Issue of Issue of The American Journal of Gastroenterology Includes Diet-Associated NAFLD Risk and Increased Risk of Mortality from COVID-19 Among PPI Users
Released: 5-Aug-2021 9:25 AM EDT
August Issue of Issue of The American Journal of Gastroenterology Includes Diet-Associated NAFLD Risk and Increased Risk of Mortality from COVID-19 Among PPI Users
American College of Gastroenterology (ACG)

The August issue of The American Journal of Gastroenterology includes clinical discussions of diet-associated NAFLD risk and increased risk of mortality from COVID-19 among PPI users. In addition, this issue features clinical research and reviews on IBS, gender barriers for CRC screening, hepatitis C, eosinophilic esophagitis, and more.

Released: 5-Aug-2021 8:45 AM EDT
Research Reveals that Flu Shot Protects Against Severe Effects of COVID-19
University of Miami Health System, Miller School of Medicine

In a newly published study, physician-scientists at the University of Miami Miller School of Medicine have shown that the flu vaccine may provide vital protection against COVID-19.

Released: 5-Aug-2021 8:45 AM EDT
Persistent COVID-19 Infections in Immunocompromised People May Give Rise to Variants of Concern
Fred Hutchinson Cancer Research Center

In an article in the New England Journal of Medicine, scientists from Fred Hutchinson Cancer Research Center, Johns Hopkins Bloomberg School of Medicine, the U.S. Military HIV Research Program and the Institute for Global Health and Infectious Diseases at the University of North Carolina urged increased attention to persistent COVID-19 infections in immunocompromised people.

Newswise: Novel Model Predicts COVID-19 Outbreak Two Weeks Ahead of Time
Released: 5-Aug-2021 8:30 AM EDT
Novel Model Predicts COVID-19 Outbreak Two Weeks Ahead of Time
Florida Atlantic University

People’s social behavior, reflected in their mobility data, is providing scientists with a way to forecast the spread of COVID-19 nationwide at the county level. Researchers have developed the first data-driven deep learning model with the potential to predict an outbreak in COVID-19 cases two weeks in advance. Feeding the mobility data to epidemiological forecasting models helps to estimate COVID-19 growth as well as evaluating the effects of government policies such as mandating masks on the spread of COVID-19.


Showing results

110 of 6133

close
2.99332